Skip to main content

Table 2 CMV-specific testing a by presence or absence of a code for CMV-associated conditions among infants ≤1 month of age and infants with routine laboratory testing, MarketScan 2011 bc

From: Laboratory testing and diagnostic coding for cytomegalovirus among privately insured infants in the United States: a retrospective study using administrative claims data

CMV-associated conditionc

Infants

N=368,266

Infants with Routine Laboratory Testingd

N=38,344

Total

Tested

P-value

Total

Tested

P-value

#

# (%)

#

# (%)

Chorioretinitis

      

  No

368,253

229 (0.06)

1.00

38,340

129 (0.34)

1.00

  Yes

13

0 (0.00)

 

4

0 (0.00)

 

Encephalitis

      

  No

368,254

229 (0.06)

1.00

38,344

129 (0.34)

NA

  Yes

12

0 (0.00)

 

0

  

Hepatomegaly

      

  No

368,221

224 (0.06)

<0.01

38,336

126 (0.33)

<0.01

  Yes

45

5 (11.11)

 

8

3 (37.50)

 

Jaundice

      

  No

257,269

175 (0.07)

0.03

24,584

92 (0.37)

0.09

  Yes

110,997

54 (0.05)

 

13,760

37 (0.27)

 

Low Birth Weight

      

  No

334,333

90 (0.03)

<0.01

34,570

46 (0.13)

<0.01

  Yes

33,933

139 (0.41)

 

3,774

83 (2.20)

 

Microcephaly

      

  No

368,151

224 (0.06)

<0.01

38,328

127 (0.33)

<0.01

  Yes

115

5 (4.35)

 

16

2 (12.50)

 

Other Congenital Anomalies of Nervous System

      

  No

367,278

205 (0.06)

<0.01

38,206

116 (0.30)

<0.01

  Yes

988

24 (2.43)

 

138

13 (9.42)

 

Petechiae

      

  No

366,616

228 (0.06)

1.00

38,134

129 (0.34)

1.00

  Yes

1,650

1 (0.06)

 

210

0 (0.00)

 

Seizures

      

  No

367,209

208 (0.06)

<0.01

38,210

116 (0.30)

<0.01

  Yes

1,057

21 (1.99)

 

134

13 (9.70)

 

Splenomegaly

      

  No

368,256

229 (0.06)

1.00

38,343

129 (0.34)

1.00

  Yes

10

0 (0.00)

 

1

0 (0.00)

 

Thrombocytopenia

      

  No

367,146

193 (0.05)

<0.01

38,156

108 (0.28)

<0.01

  Yes

1,120

36 (3.21)

 

188

21 (11.17)

 

Any of the above 11 CMV-associated conditions

      

  No

231,409

42 (0.02)

<0.01

21,968

19 (0.09)

<0.01

  Yes

136,857

187 (0.14)

 

16,376

110 (0.67)

 
  1. a CMV-specific testing includes CMV serologic testing (CMV IgG, CMV IgM, and CMV EIA), CMV DFA, and CMV PCR testing. (See Additional file 1: Table S1 for CPT codes).
  2. bInfants are defined as enrollees ≤ 1 month of age with ≥1 medical claim within 30 days of a newborn code (defined as either a code for live birth, or observation and evaluation of newborns and infants; codes defined in Additional file 1: Table S1).
  3. cSee Additional file 1: Table S1 for ICD-9-CM and CPT codes used to identify CMV-associated conditions.
  4. d Infants with ≥1 codes for other routinely recommended laboratory tests that are typically performed on infants as part of standard care. These tests included phenylketonuria, hypothyroidism, galactosemia, and hemoglobinopathies.